For the quarter ending 2025-09-30, IMNM has $299,377K in assets. $35,458K in debts. $272,639K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 272,639 | 143,876 | ||
| Marketable securities | 0 | 124,160 | ||
| Prepaid expenses and other current assets | 7,285 | 9,396 | ||
| Total current assets | 279,924 | 277,432 | ||
| Property and equipment, net | 11,563 | 11,025 | ||
| Operating right-of-use assets | 3,125 | 3,269 | ||
| Restricted cash | 210 | 210 | ||
| Other long-term assets | 4,555 | 4,354 | ||
| Total assets | 299,377 | 296,290 | ||
| Accounts payable | 6,147 | 4,660 | ||
| Accrued expenses and other current liabilities | 25,298 | 18,218 | ||
| Deferred revenue, current | 0 | 0 | ||
| Total current liabilities | 31,445 | 22,878 | ||
| Operating lease liabilities, net of current portion | 4,013 | 4,142 | ||
| Total liabilities | 35,458 | 27,020 | ||
| Common stock, 0.0001 par value 300,000,000 shares authorized at september 30, 2025 and december 31, 2024 91,706,948 and 64,460,829 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 9 | 9 | ||
| Additional paid-in capital | 922,174 | 870,092 | ||
| Accumulated other comprehensive income | 0 | -24 | ||
| Accumulated deficit | -658,264 | -600,807 | ||
| Total stockholders' equity | 263,919 | 269,270 | ||
| Total liabilities and stockholders' equity | 299,377 | 296,290 | ||
Immunome Inc. (IMNM)
Immunome Inc. (IMNM)